The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience

Table 1

Characteristics of the patients.

Characteristics	𝑁. (%)
Patients	24
Sex
Male	13 (54%)
Female	9 (46%)
Median age (years)	54 (32–77)
KPS	90–100
Histology
Glioblastoma	100%
PTS with GTR >98%	19 (79%)
PTS with GTR >90%	5 (21%)
PTS with methylated MGMT	10/17 (59%)
PTS with unmethylated MGMT	7/17 (41%)

KPS: Karnofsky performance status; MGMT: O6-methylguanine-DNA methyltransferase; PTS: patients; GTR: gross-total resection.